Comparison of demographic and donation profiles and transfusion- transmissible disease markers and risk rates in previously transfused and nontransfused blood donors

Transfusion

Volumn 44, Issue 8, 2004, Pages 1243-1251

  Wang, Baoguang ^a   Higgins, M J ^b   Kleinman, S ^b   Schreiber, G B ^b   Murphy, E L ^b   Glynn, S A ^b   Wright, D J ^b   Nass, C C ^b   Chang, D ^b   Busch, M P ^b  

^a WESTAT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CREUTZFELDT JAKOB DISEASE; DISEASE MARKER; FEMALE; FRANCE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; UNITED KINGDOM; UNITED STATES; VIRUS TRANSMISSION;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK;

EID: 3342902745     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.04034.x     Document Type: Article

References (31)

1. Busch MP. Closing the windows on viral transmission by blood transfusion. In: Stramer SL, ed. Blood safety in the new millennium. Bethesda: American Association of Blood Banks; 2001:33-54.
2. AuBuchon JP, Birkmeyer JD, Busch MP. Safety of the blood supply in the United States: opportunities and controversies. Ann Intern Med 1997;127:904-9.
3. Lackritz EM. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. AIDS 1998;12(Suppl A): S81-6.
4. Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999;353:359-63.
5. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: first of two parts: blood transfusion. N Engl J Med 1999;340:438-47.
6. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
7. Prowse CV, MacGregor IR. Mad cows and Englishmen: an update on blood and vCJD. Vox Sang 2002;83(Suppl 1):341-9.
8. CJD fears prompt blood donor ban (Internet). London: BBC News; 2004 Mar 16. Available from: http://news.bbc.co.uk/l/hi/health/3515358.stm
9. America's Blood Centers. Blood shortages strain national supply, leaving many parts of the country with less than a one-day supply. ABC Newsletter 2003 Jan 17:1-2.
10. Zuck TF, Thomson RA, Schreiber GB, et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995;35:944-51.
11. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
12. Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991-1996. JAMA 2000;284:229-35.
13. Glynn SA, Smith JW, Schreiber GB, et al. Repeat whole blood and platelet apheresis donors: unreported deferrable risks, reactive screening tests and response to incentive programs. Transfusion 2001;41:736-43.
14. Wright DJ, Glynn SA, Busch M, et al. A proposed new method to estimate hepatitis B incidence rates based on HBsAg marker. Transfusion 1999;39S:106S.
15. Rosner B. Fundamentals of Biostatistics. 3rd ed. Boston: PWS-KENT Publishing Co.; 1990:88-106.
16. WESVAR PC. Version 4. Rockville (MD): Westat; 2000.
17. Kleinman S, Marshall D, AuBuchon J, Patton M. Survival after transfusion as assessed in a large multistate US cohort. Transfusion 2004;44:386-90.
18. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26:62S-5S.
19. Chiavetta JA, Ennis M, Gula CA, Baker AD, Chambers TL. Test-seeking as motivation in volunteer blood donors. Transfus Med Rev 2000;14:205-15.
20. Stigum H, Bosnes V, Magnus P, Orjasaeter H. Risk behaviour among blood donors who give blood in order to be tested for the human immunodeficiency virus. Vox Sang 2001;80:24-7.
21. Pillavin JA. Why do they give the gift of life? A review of research on blood donors since 1977. Transfusion 1990;30:444-59.
22. Oswalt RM. A review of blood donor motivation and recruitment. Transfusion 1977;17:123-35.
23. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-6.
24. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 2000;31:756-62.
25. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003;289:959-62.
26. Busch M, Chamberland M, Epstein J, et al. Oversight and monitoring of blood safely in the United States. Vox Sang 1999;77:67-76.
27. Chamberland ME. Emerging infectious agents: do they pose a risk to the safely of transfused blood and blood products? Clin Infect Dis 2002;34:797-805.
28. Dodd RY, Natari IVEP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002;42:975-9.
29. Damesyn MA, Glynn GA, Schreiber GB, et al. Behavioral and infectious disease risks in young blood donors: implications for recruitment. Transfusion 2003;43:1596-603.
30. Centers for Disease Control and Prevention. Bovine spongiform encephalopathy in a dairy cow-Washington State, 2003. MMWR Morb Mortal Wkly Rep 2004;52:1280-5.
31. Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. JAMA 1997;277:967-72.